Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATPET: Antibiotics for Perineal Tear
NCT04763486Unknown
- Sponsor
- Meir Medical Center
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin in puerperal infection (2 arms), sponsored by Meir Medical Center. Primary endpoint: Number of participants with a fever after delivery at 6 weeks. Status: unknown.
02
Drugs
cefazolin
03
Conditions
puerperal infection
Beyond the preview
Go deeper on NCT04763486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04763486.